Amphastar Pharmaceuticals, Inc.
AMPH
$27.23
-$0.36-1.29%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 276.21M | 231.75M | 236.88M | 221.65M | 250.49M |
| Total Receivables | 148.87M | 145.59M | 145.39M | 144.04M | 144.98M |
| Inventory | 185.93M | 191.73M | 185.48M | 153.74M | 130.32M |
| Prepaid Expenses | 26.02M | 9.33M | 11.77M | 12.21M | 17.72M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.44M | 2.44M | 8.44M | 2.44M | 2.44M |
| Total Current Assets | 639.47M | 580.83M | 587.96M | 534.07M | 545.95M |
|
|
|||||
| Total Current Assets | 639.47M | 580.83M | 587.96M | 534.07M | 545.95M |
| Net Property, Plant & Equipment | 353.53M | 354.73M | 353.76M | 344.63M | 327.52M |
| Long-term Investments | 3.40M | 3.40M | 3.16M | 3.05M | 3.26M |
| Goodwill | 3.40M | 3.40M | 3.16M | 3.05M | 3.26M |
| Total Other Intangibles | 568.83M | 575.10M | 581.37M | 587.61M | 591.54M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 100.99M | 99.22M | 94.12M | 97.12M | 76.92M |
| Total Assets | 1.67B | 1.62B | 1.63B | 1.58B | 1.55B |
|
|
|||||
| Total Accounts Payable | 40.54M | 41.88M | 52.81M | 30.51M | 34.09M |
| Total Accrued Expenses | 96.25M | 105.44M | 105.94M | 111.57M | 104.89M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 8.75M | 8.81M | 7.97M | 7.04M | 4.46M |
| Total Finance Division Other Current Liabilities | 59.69M | 20.28M | 32.33M | 24.64M | 15.57M |
| Total Other Current Liabilities | 59.69M | 20.28M | 32.33M | 24.64M | 15.57M |
| Total Current Liabilities | 205.23M | 176.41M | 199.05M | 173.76M | 159.01M |
|
|
|||||
| Total Current Liabilities | 205.23M | 176.41M | 199.05M | 173.76M | 159.01M |
| Long-Term Debt | 608.28M | 607.38M | 603.48M | 601.41M | 595.96M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 39.74M | 39.31M | 41.09M | 42.11M | 29.43M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 36.23M | 34.75M | 31.38M | 27.90M | 33.10M |
| Total Liabilities | 889.48M | 857.85M | 874.99M | 845.17M | 817.50M |
|
|
|||||
| Common Stock & APIC | 527.22M | 520.59M | 509.11M | 505.41M | 496.43M |
| Retained Earnings | 642.45M | 625.10M | 594.07M | 568.79M | 530.82M |
| Treasury Stock & Other | -392.93M | -388.21M | -351.90M | -341.90M | -299.58M |
| Total Common Equity | 776.75M | 757.48M | 751.28M | 732.30M | 727.68M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 776.75M | 757.48M | 751.28M | 732.30M | 727.68M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 776.75M | 757.48M | 751.28M | 732.30M | 727.68M |
|
|
|||||